The PE Ratio as of July 2024 (TTM) for China SXT Pharmaceuticals, Inc. (SXTC) is -0.05

According to China SXT Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.05. This represents a change of -80.45% compared to the average of -0.26 of the last 4 quarters.

China SXT Pharmaceuticals, Inc. (SXTC) Historical PE Ratio (quarterly & annually)

How has SXTC PE Ratio performed in the past?

The mean historical PE Ratio of China SXT Pharmaceuticals, Inc. over the last ten years is 34.28. The current -0.05 PE Ratio has changed -114.58% with respect to the historical average. Over the past ten years (40 quarters), SXTC's PE Ratio was at its highest in in the March 2018 quarter at 162.29. The PE Ratio was at its lowest in in the June 2022 quarter at -1.50.

China SXT Pharmaceuticals, Inc. (SXTC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of China SXT Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

China SXT Pharmaceuticals, Inc. (SXTC) Average PE Ratio

How has SXTC PE Ratio performed in the past?

The current PE Ratio of China SXT Pharmaceuticals, Inc. (SXTC) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

China SXT Pharmaceuticals, Inc. (SXTC) PE Ratio vs. Peers

How is SXTC’s PE Ratio compared to its peers?

China SXT Pharmaceuticals, Inc.’s PE Ratio is greater than Akanda Corp. (-0.16), greater than Petros Pharmaceuticals, Inc. (-0.13), greater than GelStat Corporation (-2.64), greater than Shuttle Pharmaceuticals Holdings, Inc. (-0.99), greater than Qilian International Holding Group Limited (-28.26), greater than PainReform Ltd. (-0.07), greater than Regencell Bioscience Holdings Limited (-33.94), less than Procaps Group S.A. (5.95), greater than Jupiter Wellness, Inc. (-3.87), greater than Biofrontera Inc. (-0.19), greater than FSD Pharma Inc. (-0.44), less than Acorda Therapeutics, Inc. (-0.00), greater than Lucy Scientific Discovery Inc. (-0.72), less than Shionogi & Co., Ltd. (2.97), less than Sunshine Biopharma, Inc. (-0.05), greater than Alimera Sciences, Inc. (-14.14), greater than Guardion Health Sciences, Inc. (-2.39), greater than China Pharma Holdings, Inc. (-0.92), less than Halo Collective Inc. (-0.00),

Build a custom stock screener for China SXT Pharmaceuticals, Inc. (SXTC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China SXT Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

China SXT Pharmaceuticals, Inc. (SXTC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like China SXT Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.